# AtaiBeckley Inc. (ATAI) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $7.39, market value $2.7 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). AtaiBeckley Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 555.7×**. Each dollar of revenue is priced at 555.7×, a level that requires very high margins or very fast growth to justify.
- **Price / book: 15.5×**. The shares trade at 15.5× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: -3.2%** (5-yr avg -24.9%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Return on equity: -297.5%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -35.1%**. Return on all capital, debt included, is -35.1%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -39.8%**. Each dollar of assets produces -39.8% of profit.

## Growth
- **Revenue growth (1 yr): 1227.6%**. Revenue grew 1227.6% over the last year.
- **EPS growth (1 yr): -212.9%**. Earnings per share fell 212.9%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 0.61**. Debt is 0.61 times equity, moderate leverage.
- **Net debt / EBITDA: net cash**. AtaiBeckley Inc. holds more cash than debt.
- **Altman Z-score: 17.07**. A Z-score of 17.07 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. AtaiBeckley Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: hold** (7 analysts). 7 analysts cover AtaiBeckley Inc.; the consensus is hold, with an average price target of $8.10 (+10% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 62.1%** (YTD 80.7%, 3-mo 87.1%). The shares are up 62.1% over twelve months including dividends.
- **From 52-week high: -0.8%** (126.3% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 67**. An RSI of 67 is neutral.
- **Beta (1 yr): 1.31** (volatility 79%). Beta of 1.31 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ATAI · Page: https://foliofundamentals.com/stocks/atai

Not investment advice.